文献速递胸部技术与安全SPECTCT

功能肺回避放疗与常规放疗肺癌患者纵向MAA SPECT/CT区域肺灌注反应比较

Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy.
PubMed 文献 · Br J Radiol · 2019-08-12

研究比较接受功能肺回避放疗(FLARE-RT)与常规放疗(LUNG-RT)的肺癌患者纵向MAA SPECT/CT区域肺灌注的剂量-灌注反应。FLARE-RT组在0-5 Gy剂量区间出现>10%灌注增加的患者比例高于LUNG-RT组,且剂量中点Dmid有更高趋势但未达统计学显著。作者认为功能肺回避计划可能促进部分患者低剂量区治疗后灌注增加,但患者间变异大,需进一步验证。

要点

  • FLARE-RT组8/20患者在0-5 Gy剂量区间出现>10%灌注增加,LUNG-RT组无此现象(p=0.03)。
  • FLARE-RT组剂量中点Dmid为35 GyEQD2,LUNG-RT组为21 GyEQD2,趋势更高但未达统计学显著(p=0.09)。
  • 两组剂量-反应斜率k相似(3.1-3.2,p=0.86),患者间变异大。

核心结论

  • 功能肺回避计划可能促进部分患者低剂量区治疗后灌注增加,但非平衡队列中患者间变异仍高;这些初步发现形成可检验假设,需在随机或病例匹配对照的更大队列中进一步验证。

研究设计与样本

  • 研究纳入28例原发性肺癌患者,20例来自干预性试验NCT02773238(FLARE-RT),8例来自观察性试验NCT01982123(LUNG-RT);FLARE-RT计划包含灌注肺剂量约束,LUNG-RT计划遵循临床标准;治疗前及治疗后3个月MAA SPECT/CT刚性配准至计划4D CT,肿瘤剔除后肺剂量转换为EQD2并按5 Gy分箱。

关键影像表现/征象

  • FLARE-RT组11/20(55%)患者与LUNG-RT组2/8(25%)患者观察到时间点间MAA灌注频率分布形状差异(p<0.05)。
  • FLARE-RT组8/20患者在0-5 Gy剂量区间出现>10%灌注增加(%ΔPERFmaxincrease=10-40%),LUNG-RT组无患者出现(p=0.03)。
  • 剂量中点Dmid在FLARE-RT组为35 GyEQD2,LUNG-RT组为21 GyEQD2,趋势更高但未达统计学显著(p=0.09)。
  • 剂量-反应斜率k在FLARE-RT组与LUNG-RT组相似(3.1-3.2,p=0.86)。

诊断标准与关键数值

  • 灌注变化以治疗前/后MAA-SPECT摄取百分比变化(%ΔPERF)表示,归一化至肿瘤剔除后全肺总摄取。
  • 剂量-反应数据用S型逻辑函数参数化,估计最大灌注增加(%ΔPERFmaxincrease)、最大灌注减少(%ΔPERFmaxdecrease)、剂量中点(Dmid)和剂量-反应斜率(k)。
  • FLARE-RT组8/20患者%ΔPERFmaxincrease=10-40%,LUNG-RT组无患者出现(p=0.03)。

临床应用与阅片要点

  • 功能肺回避计划可能促进部分患者低剂量区治疗后灌注增加,但患者间变异大。
  • 作者认为这些初步发现形成可检验假设,需在随机或病例匹配对照的更大队列中进一步验证。

局限性

  • 非平衡队列中患者间变异仍高。
  • 这些初步发现形成可检验假设,需在随机或病例匹配对照的更大队列中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The effect of functional lung avoidance planning on radiation dose-dependent changes in regional lung perfusion is unknown. We characterized dose-perfusion response on longitudinal perfusion single photon emission computed tomography (SPECT)/CT in two cohorts of lung cancer patients treated with and without functional lung avoidance techniques.

METHODS: The study included 28 primary lung cancer patients: 20 from interventional (NCT02773238) (FLARE-RT) and eight from observational (NCT01982123) (LUNG-RT) clinical trials. FLARE-RT treatment plans included perfused lung dose constraints while LUNG-RT plans adhered to clinical standards. Pre- and 3 month post-treatment macro-aggregated albumin (MAA) SPECT/CT scans were rigidly co-registered to planning four-dimensional CT scans. Tumour-subtracted lung dose was converted to EQD2 and sorted into 5 Gy bins. Mean dose and percent change between pre/post-RT MAA-SPECT uptake (%ΔPERF), normalized to total tumour-subtracted lung uptake, were calculated in each binned dose region. Perfusion frequency histograms of pre/post-RT MAA-SPECT were analyzed. Dose-response data were parameterized by sigmoid logistic functions to estimate maximum perfusion increase (%ΔPERFmaxincrease), maximum perfusion decrease (%ΔPERFmaxdecrease), dose midpoint (Dmid), and dose-response slope (k).

RESULTS: Differences in MAA perfusion frequency distribution shape between time points were observed in 11/20 (55%) FLARE-RT and 2/8 (25%) LUNG-RT patients (p < 0.05). FLARE-RT dose response was characterized by >10% perfusion increase in the 0-5 Gy dose bin for 8/20 patients (%ΔPERFmaxincrease = 10-40%), which was not observed in any LUNG-RT patients (p = 0.03). The dose midpoint Dmid at which relative perfusion declined by 50% trended higher in FLARE-RT compared to LUNG-RT cohorts (35 GyEQD2 vs 21 GyEQD2, p = 0.09), while the dose-response slope k was similar between FLARE-RT and LUNG-RT cohorts (3.1-3.2, p = 0.86).

CONCLUSION: Functional lung avoidance planning may promote increased post-treatment perfusion in low dose regions for select patients, though inter-patient variability remains high in unbalanced cohorts. These preliminary findings form testable hypotheses that warrant subsequent validation in larger cohorts within randomized or case-matched control investigations.

ADVANCES IN KNOWLEDGE: This novel preliminary study reports differences in dose-response relationships between patients receiving functional lung avoidance radiation therapy (FLARE-RT) and those receiving conventionally planned radiation therapy (LUNG-RT). Following further validation and testing of these effects in larger patient populations, individualized estimation of regional lung perfusion dose-response may help refine future risk-adaptive strategies to minimize lung function deficits and toxicity incidence.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Thomas HMT, Zeng J, Lee HJ, et al. Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy. Br J Radiol. 2019. PMID: 31364397. doi:10.1259/bjr.20190174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。